US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.98 ▲+0.52% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.49 ▼-3.19% MSFT $529.30 ▲+0.78%
FinancialContent

Articles published by Brii Biosciences

News headline image
Brii Biosciences and VBI Vaccines Present Positive Data from Completed Phase 1b/2a Study on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 2021
From Brii Biosciences
Via Business Wire
Tickers VBIV
News headline image
Brii Biosciences to Present Updated Phase 1b/2a Data on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 2021
From Brii Biosciences
Via Business Wire
News headline image
Brii Biosciences Provides Update on Strategic Clinical Development Progress
From Brii Biosciences
Via Business Wire
News headline image
Brii Biosciences Monoclonal Antibodies, BRII-196 and BRII-198, Progress to Phase 3 in NIH ACTIV-2 Trial in Ambulatory COVID-19 Patients
From Brii Biosciences
Via Business Wire